92.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$91.96
Aprire:
$92.05
Volume 24 ore:
5.16M
Relative Volume:
0.69
Capitalizzazione di mercato:
$118.96B
Reddito:
$34.20B
Utile/perdita netta:
$4.69B
Rapporto P/E:
25.57
EPS:
3.63
Flusso di cassa netto:
$5.30B
1 W Prestazione:
+0.11%
1M Prestazione:
+0.40%
6M Prestazione:
+2.28%
1 anno Prestazione:
+5.24%
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MDT
Medtronic Plc
|
92.81 | 117.96B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
ABT
Abbott Laboratories
|
132.66 | 228.64B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
105.50 | 156.70B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
391.41 | 148.97B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
EW
Edwards Lifesciences Corp
|
81.34 | 47.69B | 5.69B | 1.41B | 577.90M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
2025-06-16 | Iniziato | Leerink Partners | Outperform |
2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2024-08-21 | Reiterato | Oppenheimer | Perform |
2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
2024-08-14 | Downgrade | Stifel | Buy → Hold |
2024-05-30 | Iniziato | Goldman | Sell |
2023-07-19 | Iniziato | Robert W. Baird | Neutral |
2023-06-30 | Iniziato | CL King | Buy |
2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-03-29 | Downgrade | UBS | Buy → Sell |
2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
2022-10-18 | Iniziato | Barclays | Equal Weight |
2022-10-13 | Iniziato | Mizuho | Buy |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
2022-07-06 | Iniziato | Wolfe Research | Underperform |
2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
2022-05-27 | Downgrade | Needham | Buy → Hold |
2022-04-13 | Downgrade | Truist | Buy → Hold |
2022-03-02 | Ripresa | BofA Securities | Buy |
2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
2021-06-10 | Ripresa | Cowen | Outperform |
2021-05-25 | Iniziato | Barclays | Equal Weight |
2021-04-15 | Iniziato | Atlantic Equities | Overweight |
2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
2020-03-05 | Iniziato | Citigroup | Buy |
2020-02-13 | Iniziato | Goldman | Sell |
2020-01-08 | Iniziato | SunTrust | Buy |
2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
2019-02-04 | Reiterato | Needham | Strong Buy |
2019-01-03 | Iniziato | Deutsche Bank | Buy |
2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
2018-11-28 | Iniziato | UBS | Buy |
2018-10-16 | Iniziato | Barclays | Overweight |
2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Is Medtronic plc stock bottoming out2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
Analyzing Medtronic plc with risk reward ratio chartsEarnings Overview Summary & Fast Exit and Entry Trade Guides - Newser
Real time pattern detection on Medtronic plc stockTrade Risk Assessment & Community Verified Trade Signals - Newser
Using portfolio simulators with Medtronic plc includedMarket Risk Report & Consistent Income Trade Recommendations - Newser
Applying chart zones and confluence areas to Medtronic plcWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Ranking Medtronic plc among high performing stocks via toolsEarnings Summary Report & Expert Curated Trade Setup Alerts - Newser
Can volume confirm reversal in Medtronic plcJuly 2025 Selloffs & Risk Managed Investment Strategies - Newser
Medtronic plc stock outlook for YEARIPO Watch & Free Fast Gain Swing Trade Alerts - Newser
Medtronic executives to speak at upcoming investor conferences - The Malaysian Reserve
Analyzing recovery setups for Medtronic plc investorsPortfolio Profit Report & Community Supported Trade Ideas - Newser
Precision Trading with Medtronic Plc. (MDT) Risk Zones - news.stocktradersdaily.com
What MACD and RSI say about Medtronic plcChart Signals & Momentum Based Trading Ideas - Newser
Will Medtronic plc benefit from macro trendsWeekly Trend Report & Weekly Setup with ROI Potential - Newser
Live market analysis of Medtronic plcProfit Target & Risk Managed Investment Strategies - Newser
Published on: 2025-08-29 17:30:06 - Newser
Smart tools for monitoring Medtronic plc’s price actionDay Trade & AI Enhanced Execution Alerts - Newser
Medtronic TAVR Systems Get FDA Approval for Expanded Redo TAVR Indication - Diagnostic and Interventional Cardiology
Medtronic's Strategic Visibility and Investor Engagement in 2025 - AInvest
Medtronic to participate in investor conferences in September. - AInvest
Global Healthcare Giant Medtronic's Top Executives Set for Four Major Investment Conferences in September - Stock Titan
Medtronic Executives To Speak At Upcoming Investor Conferences - Barchart.com
How to monitor Medtronic plc with trend dashboardsWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
Medtronic plc’s volatility index tracking explainedDividend Hike & Daily Chart Pattern Signal Reports - Newser
DBS Bank Adjusts Price Target on Medtronic to $92 From $82, Maintains Hold Rating - MarketScreener
How to use a screener to detect Medtronic plc breakoutsWeekly Investment Report & Low Drawdown Momentum Ideas - Newser
Building trade automation scripts for Medtronic plcQuarterly Market Summary & Technical Pattern Recognition Alerts - Newser
Medtronic plc stock trend outlook and recovery pathQuarterly Risk Review & Accurate Entry and Exit Point Alerts - Newser
FDA approves Medtronic Evolut for expanded redo TAVR indication - BioWorld MedTech
Quantitative breakdown of Medtronic plc recent moveQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Medtronic plc Shows Support at Fibonacci Level getLinesFromResByArray error: size == 0 - thegnnews.com
Medtronic : FY25 Irish Financial Report - MarketScreener
Can Medtronic plc recover in the next quarterJuly 2025 Selloffs & AI Driven Price Predictions - Newser
Telehealth and Telemedicine Company Evaluation Report 2025 | Medtronic, Teladoc Health, and Cisco Systems Lead with Expansive Portfolios, Strategic Partnerships, and Cutting-Edge Technologies - GlobeNewswire Inc.
Medtronic plc stock momentum explainedWeekly Stock Recap & Long-Term Growth Plans - Newser
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):